...
首页> 外文期刊>Forensic science international >Toxicological analysis of cocaine adulterants in blood samples
【24h】

Toxicological analysis of cocaine adulterants in blood samples

机译:血液样本中可卡因掺假剂的毒理学分析

获取原文
获取原文并翻译 | 示例

摘要

Cocaine was the second most widely used drug in Europe in 2016, with 3.5 million consumers aged 15-64 years old. Adulterants are pharmacologically active substances developed for medical purposes, however, there is little knowledge about their influence in the human body when there is concomitant use with cocaine. The objective of this work was to validate a method that allows the identification, confirmation and quantification of cocaine adulterants in blood samples collected in vivo or post-mortem. The studied substances were atropine, phenacetin, hydroxyzine, ketamine, lidocaine and tetramisole. A retrospective study of the prevalence of these substances, as well as their relative concentrations, was made analysing 97 real blood samples previously tested positive for cocaine and/or its metabolites. The analytes of interest were extracted, using a simple method based on protein precipitation with frozen acetonitrile and further analysis by GC/MS. The method was fully validated in accordance with parameters and criteria implemented in the lab and SWGTOX recommendations (mean recovery: 94-115%; CV: 6.2-13%; BIAS: 2.7-7.8%). 31 samples were positive for adulterants: phenacetin (19%), tetramisole (15%), lidocaine (8%) and hydroxyzine (1%). Concentrations were higher in post-mortem samples for all compounds analysed. Lidocaine was more prevalent in samples collected in vivo whereas tetramisole was present almost exclusively in post-mortem samples. Phenacetin was evenly distributed between post-mortem and in vivo samples. The validated method allows rapid, precise, accurate and economic analysis of selected compounds and requires smaller sample aliquots which can be important in post-mortem cases. The information collected can be important in future studies of correlation between the presence of adulterants and cocaine toxicity. (C) 2019 Elsevier B.V. All rights reserved.
机译:可卡因于2016年是欧洲第二次使用的药物第二次,占有350万年计15-64岁的消费者。掺杂剂是用于医疗目的的药理学活性物质,但是,当随着可卡因伴随时,对人体的影响几乎没有了解。这项工作的目的是验证一种方法,该方法允许在体内或验尸中收集的血液样本中的可卡因掺杂剂的鉴定,确认和定量。研究的物质是阿托品,苯甲素,羟基,氯胺酮,利多卡因和四氨基。对这些物质的患病率以及它们的相对浓度的回顾性研究分析了先前测试了可卡因和/或其代谢物阳性的97个真实血液样品。利用基于蛋白质沉淀的简单方法用冷冻乙腈和通过GC / MS进行进一步分析,提取利益的分析物。该方法根据实验室和SWGTOX建议实施的参数和标准进行全面验证(平均回收:94-115%; CV:6.2-13%;偏见:2.7-7.8%)。 31个样品对于掺假剂阳性:苯甲素(19%),四氟(15%),利多卡因(8%)和羟基(1%)。分析所有化合物的验验后样品中浓度较高。 Lidocaine在体内收集的样品中更普遍,而四氨醇几乎完全存在于验尸后的样品中。 Phenacetin在验尸和体内样品之间均匀分布。验证的方法允许对所选化合物的快速,精确,准确和经济分析,并且需要较小的样品等分试样,这在后验尸案例中可能重要。收集的信息在未来的研究存在与掺假毒性和可卡因毒性之间的相关性的研究中可能是重要的。 (c)2019年Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号